This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to .beta.-aminotetralin-derived ureas that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.

 
Web www.patentalert.com

< Beta-lapachone and methods of treating cancer

< Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same

> Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B

> Solid formulations of ospemifene
~ 00203